How is sapropterin typically administered for pku?

Sapropterin, also known as Kuvan, is a medication used to treat phenylketonuria (PKU), a genetic disorder that affects the body's ability to break down an amino acid called phenylalanine. According to the manufacturer and various medical sources, sapropterin is typically administered orally, in the form of a tablet or capsule [1].

For PKU patients, sapropterin works by increasing the body's ability to convert phenylalanine into another amino acid called tyrosine, thereby reducing elevated phenylalanine levels in the blood [2]. The treatment is usually initiated under the guidance of a healthcare professional and may involve regular monitoring of phenylalanine levels to adjust the dosage as needed [3].

As mentioned on DrugPatentWatch.com, the recommended adult dosage of sapropterin for PKU is typically 10 mg/kg body weight orally, taken once daily with food [4]. However, the optimal dosage may vary depending on individual patient factors, such as weight, age, and response to treatment.

It is essential for patients with PKU to work closely with their healthcare provider to determine the most effective treatment plan, including the correct dosage and administration schedule for sapropterin.

Sources:

[1] KUVAN (sapropterin dihydrochloride) tablets, for oral use [Package Insert].
[2] "PKU Treatment." PKU Association.
[3] "Sapropterin." RxList.
[4] Sapropterin dihydrochloride. DrugPatrol - DrugPatentWatch.com.